Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Captopril Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101289417B details an advanced purification process for D-3-thioacetyl-2-methylpropionyl-L-proline, offering superior yield and optical purity for captopril manufacturing.
Patent CN111039838A reveals a low-cost, high-yield synthesis route for 3-acetylmercapto-2-methylpropanoic acid, offering significant supply chain advantages for API manufacturers.
Novel chiral resolution method for captopril intermediate ensures high purity and scalable production for reliable pharmaceutical intermediates supplier partnerships.